A. ÖZKAN And K. FIŞKIN, "Cytotoxicities of low dose epirubicin-HCI combining lymphokine activated killer cell against hepatocellular carcinoma cell line hepatoma G2.," Turkish Journal of Medical Sciences , vol.34, pp.11-19, 2004
ÖZKAN, A. And FIŞKIN, K. 2004. Cytotoxicities of low dose epirubicin-HCI combining lymphokine activated killer cell against hepatocellular carcinoma cell line hepatoma G2.. Turkish Journal of Medical Sciences , vol.34 , 11-19.
ÖZKAN, A., & FIŞKIN, K., (2004). Cytotoxicities of low dose epirubicin-HCI combining lymphokine activated killer cell against hepatocellular carcinoma cell line hepatoma G2.. Turkish Journal of Medical Sciences , vol.34, 11-19.
ÖZKAN, AYSUN, And KAYAHAN FIŞKIN. "Cytotoxicities of low dose epirubicin-HCI combining lymphokine activated killer cell against hepatocellular carcinoma cell line hepatoma G2.," Turkish Journal of Medical Sciences , vol.34, 11-19, 2004
ÖZKAN, AYSUN And FIŞKIN, KAYAHAN. "Cytotoxicities of low dose epirubicin-HCI combining lymphokine activated killer cell against hepatocellular carcinoma cell line hepatoma G2.." Turkish Journal of Medical Sciences , vol.34, pp.11-19, 2004
ÖZKAN, A. And FIŞKIN, K. (2004) . "Cytotoxicities of low dose epirubicin-HCI combining lymphokine activated killer cell against hepatocellular carcinoma cell line hepatoma G2.." Turkish Journal of Medical Sciences , vol.34, pp.11-19.
@article{article, author={AYSUN ÖZKAN And author={KAYAHAN FIŞKIN}, title={Cytotoxicities of low dose epirubicin-HCI combining lymphokine activated killer cell against hepatocellular carcinoma cell line hepatoma G2.}, journal={Turkish Journal of Medical Sciences}, year=2004, pages={11-19} }